NPI: 1386608586 · WOODBRIDGE, VA 22192 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/14/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/14/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 17,478 | $439K |
| 2019 | 17,390 | $316K |
| 2020 | 22,356 | $698K |
| 2021 | 20,561 | $531K |
| 2022 | 16,357 | $756K |
| 2023 | 9,951 | $798K |
| 2024 | 4,025 | $341K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 29,670 | 1,853 | $1.92M |
| 90935 | Hemodialysis procedure with single evaluation by a physician | 10,261 | 857 | $1.73M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 28,083 | 1,569 | $110K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,014 | 465 | $54K |
| A4657 | Syringe, with or without needle, each | 8,139 | 1,673 | $26K |
| J1756 | Injection, iron sucrose, 1 mg | 8,863 | 1,795 | $23K |
| J1270 | Injection, doxercalciferol, 1 mcg | 18,475 | 1,333 | $7K |
| 90674 | 84 | 60 | $594.61 | |
| G0008 | Administration of influenza virus vaccine | 95 | 69 | $296.55 |
| 83970 | 661 | 342 | $95.75 | |
| 0011A | 20 | 14 | $50.82 | |
| 0012A | 18 | 13 | $40.00 | |
| 85041 | 894 | 567 | $18.46 | |
| 85048 | 886 | 559 | $17.03 | |
| 82728 | 303 | 197 | $7.09 | |
| 83550 | 302 | 197 | $4.56 | |
| 83540 | 303 | 197 | $3.36 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 47 | 27 | $0.00 |